BIOMAT Database Logo BIOMAT Database Logo

Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. 1999

H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL 35294, USA.

Autocrine interaction of Fas and Fas ligand leads to apoptosis of activated T cells, a process that is critical for the maintenance of peripheral T cell tolerance. Paracrine interactions of Fas ligand with T cells also may play an important role in the maintenance of tolerance, as Fas ligand can create immune-privileged sites and prevent graft rejection by inducing apoptosis in T cells. We surmised that APCs that express Fas ligand might directly induce apoptosis of T cells during presentation of Ag to the T cells, thus inducing Ag-specific, systemic T cell tolerance. Here, we show that profound, specific T cell unresponsiveness to alloantigen was induced by treatment of H-2k mice with H-2b APCs that expressed Fas ligand and that profound T cell unresponsiveness specific for the H-Y Ag was induced by treatment of H-2Db/H-Y TCR transgenic female mice with H-2Db/H-Y APCs that expressed Fas ligand. The induction of this systemic T cell tolerance required the expression of Fas ligand on the APCs as well as the expression of Fas on the T cells. The tolerance was restricted to the Ag presented by the APCs. The rapid and profound clonal deletion of the Ag-specific, peripheral T cells mediated by the Fas ligand-expressing APCs contributed to the induction of tolerance. These findings demonstrate that Ag-specific T cell tolerance can be induced by APCs that express Fas ligand and suggest a novel function for APCs in the induction of T cell apoptosis. Furthermore, they indicate a novel immunointervention strategy for treatment of graft rejection and autoantigen-specific autoimmune diseases.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D005260 Female Females

Related Publications

H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells.
November 1998, Nature biotechnology,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Specific T cell deletion by transfected human monocytes expressing fas ligand and antigen.
June 2000, Human immunology,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Specific T-cell deletion by transfected human monocytes expressing Fas ligand and antigen.
January 2001, Transplantation proceedings,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells.
April 2006, Journal of immunology (Baltimore, Md. : 1950),
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand.
April 2000, Human gene therapy,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Specific deletion of autoreactive T cells by adenovirus-transfected, Fas ligand-producing antigen-presenting cells.
January 2002, Immunologic research,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.
November 2003, Journal of immunology (Baltimore, Md. : 1950),
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice.
March 2000, The Journal of clinical investigation,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
September 1996, The Journal of experimental medicine,
H G Zhang, and X Su, and D Liu, and W Liu, and P Yang, and Z Wang, and C K Edwards, and H Bluethmann, and J D Mountz, and T Zhou
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
May 1993, Nature,
Copied contents to your clipboard!